Evidence map›Paper›PMID 36769528›Full record

ReviewJournal of clinical medicine2023

Artificial Neural Networks in Lung Cancer Research: A Narrative Review.

Elena Prisciandaro, Giulia Sedda, Andrea Cara, Cristina Diotti, Lorenzo Spaggiari, Luca Bertolaccini

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. AΙ-Driven Drug Repurposing: Applications and Challenges.Medicines (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elena PrisciandaroDepartment of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Giulia SeddaDepartment of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-7482-1544
Andrea CaraDepartment of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Cristina DiottiDepartment of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Lorenzo SpaggiariDepartment of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Luca BertolacciniDepartment of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-1153-3334

Funding

Ministero della Salute 5 x 1000Ministero della Salute Ricerca Corrente
6 · The paper itself

Abstract

backgroundArtificial neural networks are statistical methods that mimic complex neural connections, simulating the learning dynamics of the human brain. They play a fundamental role in clinical decision-making, although their success depends on good integration with clinical protocols. When applied to lung cancer research, artificial neural networks do not aim to be biologically realistic, but rather to provide efficient models for nonlinear regression or classification.

methodsWe conducted a comprehensive search of EMBASE (via Ovid), MEDLINE (via PubMed), Cochrane CENTRAL, and Google Scholar from April 2018 to December 2022, using a combination of keywords and related terms for "artificial neural network", "lung cancer", "non-small cell lung cancer", "diagnosis", and "treatment".

resultsArtificial neural networks have shown excellent aptitude in learning the relationships between the input/output mapping from a given dataset, without any prior information or assumptions about the statistical distribution of the data. They can simultaneously process numerous variables, managing complexity; hence, they have found broad application in tasks requiring attention.

conclusionsLung cancer is the most common and lethal form of tumor, with limited diagnostic and treatment methods. The advances in tailored medicine have led to the development of novel tools for diagnosis and treatment. Artificial neural networks can provide valuable support for both basic research and clinical decision-making. Therefore, tight cooperation among surgeons, oncologists, and biostatisticians appears mandatory.

Indexed as

artificial neural networklung cancerNSCLC

Identifiers

PMID36769528
PMCPMC9918295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.